Queensland scientists push for new national treatment guidelines for chronic fatigue syndrome
Research in the last 20 years clearly outlines that myalgic encephalomyelitis, or chronic fatigue syndrome, is not a psychological or psychiatric illness. Patients with ME/CFS can experience a range of symptoms including brain fog, confusion, difficulties with memory and concentration, sleep disturbances, heart problems, muscle and joint pain and intolerances to temperature, light and noise. Professor Marshall-Gradisnik and her team at Griffith University's National Centre for Neuro-immunology and Emerging Diseases, have found dysfunction in the cells of patients with ME/CFS patients, which "align to the symptom presentation" of people with the condition. "They can't bring calcium inside these cells. Calcium is important for all cell functions," she said.
The Griffith University research has identified low-dose Naltrexone as a potential drug treatment for ME/CFS, recognised as one of a suite of post-infectious diseases that often follow a viral illness. She said participants would undergo magnetic resonance imaging scans of the brain to assess the affect of the drug on cellular dysfunction identified in ME/CFS.